Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
Published Online: 2021-08-?
Journal: The Lancet•Publisher: Elsevier BV
Authors: Akihito Tsuji•Antoine Adenis•Byoung Chul Cho•Christos Fountzilas•Eray Goekkurt•Hiroki Hara•Jean-Philippe Metges•Jong-Mu Sun•Ken Kato•Lin Shen•Luis Antunes•Manish A Shah•Maria Alsina Maqueda•Patrapim Sunpaweravong•Peter Enzinger•Pooja Bhagia•Qi Liu•Shau-Hsuan Li•Sukrut Shah•Sung-Bae Kim•Takashi Kojima•Toshihiko Doi•Victor Castro Oliden•Wasat Mansoor•Zhigang Li
